Research ArticleArticle
Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody–Associated Dermatomyositis
Ken Nagahata, Masanari Sugawara, Masatoshi Kanda and Hiroki Takahashi
The Journal of Rheumatology December 2022, jrheum.220649; DOI: https://doi.org/10.3899/jrheum.220649
Ken Nagahata
Ken Nagahata, MD, Masanari Sugawara, MD, Masatoshi Kanda, MD, PhD, Hiroki Takahashi, MD, PhD, Department of Rheumatology and Clinical Immunology, School of Medicine, Sapporo Medical University, Sapporo, Japan. Address correspondence to Dr. K. Nagahata, Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, South 1-West 16, Chuo ku, Sapporo, Hokkaido 060-8543, Japan. Email: nagahata.ken@sapmed.ac.jp. The authors declare no conflicts of interest relevant to this article. Informed consent from the patient was obtained. Ethical approval for this study was waived by Sapporo Medical University Hospital Institutional Review Board, based on the "Ethical Guidelines for Medical and Biological Research Involving Human Subjects," which states that case reports that can be considered part of medical care not for research purposes do not constitute research, prepared by the Japanese Ministry of Health, Labour and Welfare, Ministry of Education, Culture, Sports, Science and Technology, and Ministry of Economy, Trade and Industry.
Masanari Sugawara
Ken Nagahata, MD, Masanari Sugawara, MD, Masatoshi Kanda, MD, PhD, Hiroki Takahashi, MD, PhD, Department of Rheumatology and Clinical Immunology, School of Medicine, Sapporo Medical University, Sapporo, Japan. Address correspondence to Dr. K. Nagahata, Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, South 1-West 16, Chuo ku, Sapporo, Hokkaido 060-8543, Japan. Email: nagahata.ken@sapmed.ac.jp. The authors declare no conflicts of interest relevant to this article. Informed consent from the patient was obtained. Ethical approval for this study was waived by Sapporo Medical University Hospital Institutional Review Board, based on the "Ethical Guidelines for Medical and Biological Research Involving Human Subjects," which states that case reports that can be considered part of medical care not for research purposes do not constitute research, prepared by the Japanese Ministry of Health, Labour and Welfare, Ministry of Education, Culture, Sports, Science and Technology, and Ministry of Economy, Trade and Industry.
Masatoshi Kanda
Ken Nagahata, MD, Masanari Sugawara, MD, Masatoshi Kanda, MD, PhD, Hiroki Takahashi, MD, PhD, Department of Rheumatology and Clinical Immunology, School of Medicine, Sapporo Medical University, Sapporo, Japan. Address correspondence to Dr. K. Nagahata, Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, South 1-West 16, Chuo ku, Sapporo, Hokkaido 060-8543, Japan. Email: nagahata.ken@sapmed.ac.jp. The authors declare no conflicts of interest relevant to this article. Informed consent from the patient was obtained. Ethical approval for this study was waived by Sapporo Medical University Hospital Institutional Review Board, based on the "Ethical Guidelines for Medical and Biological Research Involving Human Subjects," which states that case reports that can be considered part of medical care not for research purposes do not constitute research, prepared by the Japanese Ministry of Health, Labour and Welfare, Ministry of Education, Culture, Sports, Science and Technology, and Ministry of Economy, Trade and Industry.
Hiroki Takahashi
Ken Nagahata, MD, Masanari Sugawara, MD, Masatoshi Kanda, MD, PhD, Hiroki Takahashi, MD, PhD, Department of Rheumatology and Clinical Immunology, School of Medicine, Sapporo Medical University, Sapporo, Japan. Address correspondence to Dr. K. Nagahata, Department of Rheumatology and Clinical Immunology, Sapporo Medical University School of Medicine, South 1-West 16, Chuo ku, Sapporo, Hokkaido 060-8543, Japan. Email: nagahata.ken@sapmed.ac.jp. The authors declare no conflicts of interest relevant to this article. Informed consent from the patient was obtained. Ethical approval for this study was waived by Sapporo Medical University Hospital Institutional Review Board, based on the "Ethical Guidelines for Medical and Biological Research Involving Human Subjects," which states that case reports that can be considered part of medical care not for research purposes do not constitute research, prepared by the Japanese Ministry of Health, Labour and Welfare, Ministry of Education, Culture, Sports, Science and Technology, and Ministry of Economy, Trade and Industry.

Abstract
Pneumatosis intestinalis (PI) is the presence of gas within the bowel wall and may result from several autoimmune diseases, including dermatomyositis (DM).1 A 55-year-old man with antimelanoma differentiation-associated gene 5 antibody (MDA5)-associated DM and interstitial lung disease (ILD) presented with a 1-week history of swallowing difficulty.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
The Journal of Rheumatology
Vol. 50, Issue 1
1 Jan 2023
Unrecognized Pneumatosis Intestinalis in Antimelanoma Differentiation-Associated Gene 5 Antibody–Associated Dermatomyositis
Ken Nagahata, Masanari Sugawara, Masatoshi Kanda, Hiroki Takahashi
The Journal of Rheumatology Dec 2022, jrheum.220649; DOI: 10.3899/jrheum.220649